India's first multicentre randomised controlled trial on the use of the drug Tocilizumab in Covid patients has demonstrated that an anti-inflammatory treatment reduces the risk of death among patients with severe COVID-19. The results of the trial were published this morning in one of the world's top journals, 'The Lancet Respiratory Medicine'. We spoke with the lead researcher, Dr Arvinder Singh Soin. | NDTV

1.4K views | Toss a lizard? Toxic Loo Dab? How DO you say 'Tocilizumab'? On the latest #BBCNewscast, Fergus Walsh teaches Adam Fleming. Listen now on BBC Sounds  bbc.in/2ZmK9AC | BBC Sounds | Facebook

3.2K views · 4 comments | The Food and Drug Administration of the Philippines (FDA) has asked the pharmaceutical company producing the anti-inflammatory drug tocilizumab now being used to treat COVID-19 patients for more supply as the country faces an increase in new coronavirus cases, FDA chief Eric Domingo said Friday. READ: https://newsinfo.inquirer.net/1482965/ph-fda-asks-tocilizumab-maker-for-more-supply | INQUIRER.net | Facebook